BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24014832)

  • 1. Impaired cholesterol metabolism and enhanced atherosclerosis in clock mutant mice.
    Pan X; Jiang XC; Hussain MM
    Circulation; 2013 Oct; 128(16):1758-69. PubMed ID: 24014832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
    Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
    Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36.
    Zhou F; Pan Y; Huang Z; Jia Y; Zhao X; Chen Y; Diao J; Wan Q; Cui X
    Cell Stress Chaperones; 2013 Sep; 18(5):643-52. PubMed ID: 23494402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
    FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolin protects macrophages from oxLDL-induced foam cell formation through up-regulating ABCA1 expression.
    Li Y; Jiang B; Liang P; Tong Z; Liu M; Lv Q; Liu Y; Liu X; Tang Y; Xiao X
    Biochem Biophys Res Commun; 2017 Apr; 486(2):364-371. PubMed ID: 28315324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E
    Rinne P; Kadiri JJ; Velasco-Delgado M; Nuutinen S; Viitala M; Hollmén M; Rami M; Savontaus E; Steffens S
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):313-323. PubMed ID: 29284608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis.
    Zhao JF; Ching LC; Huang YC; Chen CY; Chiang AN; Kou YR; Shyue SK; Lee TS
    Mol Nutr Food Res; 2012 May; 56(5):691-701. PubMed ID: 22648616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
    Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foam cells in atherosclerosis.
    Yu XH; Fu YC; Zhang DW; Yin K; Tang CK
    Clin Chim Acta; 2013 Sep; 424():245-52. PubMed ID: 23782937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetramethylpyrazine suppresses lipid accumulation in macrophages via upregulation of the ATP-binding cassette transporters and downregulation of scavenger receptors.
    Duan J; Xiang D; Luo H; Wang G; Ye Y; Yu C; Li X
    Oncol Rep; 2017 Oct; 38(4):2267-2276. PubMed ID: 28791414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice.
    Chandak PG; Obrowsky S; Radovic B; Doddapattar P; Aflaki E; Kratzer A; Doshi LS; Povoden S; Ahammer H; Hoefler G; Levak-Frank S; Kratky D
    Biochim Biophys Acta; 2011 Dec; 1811(12):1011-20. PubMed ID: 21924378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
    Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway.
    Pamir N; Hutchins P; Ronsein G; Vaisar T; Reardon CA; Getz GS; Lusis AJ; Heinecke JW
    J Lipid Res; 2016 Feb; 57(2):246-57. PubMed ID: 26673204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet.
    Song G; Liu J; Zhao Z; Yu Y; Tian H; Yao S; Li G; Qin S
    Lipids Health Dis; 2011 Jan; 10():8. PubMed ID: 21241519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway.
    Tan YL; Ou HX; Zhang M; Gong D; Zhao ZW; Chen LY; Xia XD; Mo ZC; Tang CK
    Curr Pharm Biotechnol; 2019; 20(5):422-432. PubMed ID: 30947667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II.
    Kuchibhotla S; Vanegas D; Kennedy DJ; Guy E; Nimako G; Morton RE; Febbraio M
    Cardiovasc Res; 2008 Apr; 78(1):185-96. PubMed ID: 18065445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCN family member 1 deregulates cholesterol metabolism and aggravates atherosclerosis.
    Zhao JF; Chen HY; Wei J; Jim Leu SJ; Lee TS
    Acta Physiol (Oxf); 2019 Mar; 225(3):e13209. PubMed ID: 30347516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
    Avallone R; Demers A; Rodrigue-Way A; Bujold K; Harb D; Anghel S; Wahli W; Marleau S; Ong H; Tremblay A
    Mol Endocrinol; 2006 Dec; 20(12):3165-78. PubMed ID: 16959872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1.
    Lv YC; Yang J; Yao F; Xie W; Tang YY; Ouyang XP; He PP; Tan YL; Li L; Zhang M; Liu D; Cayabyab FS; Zheng XL; Tang CK
    Atherosclerosis; 2015 May; 240(1):80-9. PubMed ID: 25765596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.